Professor Sarah Fidler is a clinical academic who provides care for people living with HIV. Her main research interest is in the diagnosis, treatment and cure of HIV infection.
et al., 2022, Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV, Jci Insight, Vol:7
et al., 2022, The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial, Trials, Vol:23, ISSN:1745-6215
et al., 2022, HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana, Journal of Antimicrobial Chemotherapy, Vol:77, ISSN:0305-7453, Pages:1385-1395
et al., 2022, Response to 'The use of tenofovir in patients with COVID-19', Hiv Medicine, ISSN:1464-2662
et al., 2022, Intimate Partner Violence (IPV) and Associated Factors in HPTN 071 (PopART) Study Communities in Zambia and South Africa-A Comparison by HIV Status, Aids and Behavior, Vol:26, ISSN:1090-7165, Pages:1355-1365